The status of adjuvant and neoadjuvant melanoma therapy, new developments and upcoming challenges
H Stege, M Haist, U Nikfarjam, M Schultheis, J Heinz… - Targeted …, 2021 - Springer
The global incidence of malignant melanoma, the leading cause of skin cancer death, has
steadily increased in recent years. Surgical excision is the treatment of choice for early-stage …
steadily increased in recent years. Surgical excision is the treatment of choice for early-stage …
Long‐term efficacy of neoadjuvant–adjuvant targeted therapy in borderline resectable stage IIIB–D and IV melanoma
AM Czarnecka, K Ostaszewski, PJ Błoński… - Cancer, 2024 - Wiley Online Library
Background Neoadjuvant–adjuvant therapy for locally advanced or potentially resectable
metastatic melanoma was expected to improve operability and clinical outcomes over …
metastatic melanoma was expected to improve operability and clinical outcomes over …